What were the key takeaways from Village Farms International’s earnings call?

What is Village Farms International's latest dividend and current dividend yield?

What factors drove the changes in Village Farms International's revenue and profit?

What guidance did Village Farms International's management provide for the next earnings period?

What does Village Farms International do and what are its main business segments?

What is the revenue and EPS growth rate for Village Farms International year over year?

Did Village Farms International beat or miss consensus estimates last quarter?

What is Village Farms International's gross profit margin?

- **Record Financial Performance**: 2025 net income up $49M YoY to $21M; EBITDA up $48M to $50M
- **International Growth Engine**: Netherlands exports grew 384% Q4; international exports up sixfold annually
- **Strong Cash Position**: $86M cash post $3M share buyback; $15M debt facility for expansion
- **Capacity Expansion**: 33% Canadian capacity increase by 2027; Netherlands Phase 2 on track for 2026
- **Market Leadership**: #1 dried flower in Canada; 43% gross margin vs 30-40% target
- **Strategic Repurchases**: $6.7M in share buybacks since Q4; Board-approved program continues

**【CEO Summary Section】**
- **Record 2025 Performance**: Achieved net income of $21 million (up $49 million YoY), EBITDA of $50 million (up $48 million YoY), and cash flow of $58 million (up $44 million YoY). 
- **Global Expansion Success**: 
  - Canada cannabis sales +17% YoY; Netherlands exports grew 384% in Q4
  - International exports increased sixfold annually
- **Strategic Milestones**: 
  - Netherlands Phase 1 facility profitable after 3 quarters of operation
  - Legacy produce business privatized to focus on cannabis
  - $86 million cash balance post $3M share buyback
- **Capacity Expansion**: 
  - Delta 2 expansion adding 40 metric tons (33% capacity) by mid-2027
  - Netherlands Phase 2 facility on track for Q2 2026 launch

**【CFO Financial Commentary】**
- **Q4 2025 Financials**: 
  - Net sales $49.6M (+9% YoY)
  - Net income $2.3M vs -$5.7M last year
  - EBITDA $8.6M vs -$2.9M YoY
  - Cash flow $11.4M
- **Canadian Cannabis Metrics**: 
  - Sales $52.7M (+10% YoY)
  - Gross margin 43% (vs 3% last year)
  - EBITDA $14.3M (vs -$9.1M YoY)
- **Key Costs**: 
  - Excise taxes $21.5M (40% of retail sales)
  - Income taxes $16M paid in Q1 2026
- **Balance Sheet**: 
  - $86M cash (including $5M restricted)
  - $34M debt
  - $15M delayed draw term loan for EU-GMP expansion

**【Q&A Highlights】**
- **Share Repurchases**: 
  - $3M in Q4, $3.7M in Q1 2026
  - Board-approved program allows up to 5% of shares
  - Management views current valuation as attractive
- **Germany Market**: 
  - Q4 imports down 4% due to regulatory uncertainty
  - Q1 2026 demand rebound expected
  - Village Farms' quality standards position as competitive advantage
- **Capacity Allocation**: 
  - Canada and international markets treated equally
  - Delta 2 expansion capacity will serve both
  - 2027 capacity could double 2025 levels
- **Cost Reduction**: 
  - Ongoing improvements in cultivation and SG&A
  - 2025 SG&A as % of sales down to 22% (from 28%)


Village Farms International, Inc. (VFF) Q4 2025 Earnings Call Transcript

- **Record Financials**: 21% YoY revenue growth, $10.8M net income, and 31% EBITDA margin.
- **Key Growth Drivers**: International medical exports (+758% YoY), Netherlands expansion, and cost control.
- **Strategic Moves**: Share repurchase program launched; cautious on US hemp M&A.
- **Market Leadership**: Leading EU GMP exporter with 750% YoY medical sales growth.
- **Capacity Expansion**: 33% Canadian production capacity increase underway for 2026.


**【CEO Opening Remarks】**
- Q3 2025 revenue increased 21% YoY to $66.7 million, driven by Canadian cannabis and Dutch recreational sales.
- Net income from continuing operations rose to $10.8 million ($0.09/share), up 10x Q2.
- Adjusted EBITDA reached $20.7 million (31% margin), a 309% YoY increase.
- Key growth drivers: international medical exports (+758% YoY), Netherlands expansion, and cost control.
- 40% of Canadian greenhouses now in cannabis production, with 33% capacity expansion underway.

**【CFO Financial Commentary】**
- Canadian cannabis segment: CAD 64.1 million in sales (+29% YoY), 56% gross margin (vs. 26% YoY), and CAD 26.6 million EBITDA.
- Netherlands: EUR 3.6 million in sales, 11% sequential growth, and EUR 0.3 million EBITDA.
- US hemp: $3.3 million in sales, stable amid regulatory challenges.
- Cash flow from operations: $24.4 million, up 295% YoY.
- Share repurchase program launched with $10 million authorization.

**【Q&A Highlights】**
- **Gross Margin Sustainability**: 30-40% target maintained; Q3 56% margin driven by pricing, exports, and efficiency.
- **Texas Expansion**: Monitoring regulatory changes; cautious on M&A to preserve NASDAQ listing.
- **Dutch Market Dynamics**: 5x capacity expansion underway; 91% coffee shop penetration in Netherlands.
- **Germany Market Share**: Leading EU GMP-certified exporter; 750% YoY medical sales growth.
- **Texas Hemp Business**: Stable amid regulatory headwinds; exploring new product lines.


Village Farms International, Inc. (VFF) Q3 2025 Earnings Call Transcript

- **Record Profitability**: Q2 2025 net income $9.9M, EBITDA $17.1M (29% of sales), up 2,300bps margin YoY.
- **International Surge**: Exports +690% YoY, Netherlands sales 82.5% market penetration, Phase 2 facility (4x capacity) coming online Q1 2026.
- **Canada Margin Leadership**: 39% gross margin (highest in 3 years), disciplined SKU portfolio focus.
- **Strategic Expansion**: $7M Delta 2 conversion to add 40M+ annual capacity, funded by $40M produce sale proceeds.
- **Strong Balance Sheet**: $65M cash, $39M debt, free cash flow $12M YoY.

**【CEO Summary Section】**
- **Transformational Quarter**: Q2 2025 marked record profitability, with consolidated net income from continuing operations of $9.9 million and adjusted EBITDA of $17.1 million, up 29% of sales. 
- **International Growth**: International exports surged 690% YoY, tripling 2024 sales by mid-year. Netherlands recreational sales reached 82.5% market penetration, with Phase 1 facility at full capacity and Phase 2 (4x production) set for Q1 2026.
- **Canada Focus**: Canadian cannabis gross margin hit 39% (highest in 3 years), driven by higher-margin SKUs and reduced low-margin sales. 
- **Expansion Announcement**: Conversion of 550k sq ft Delta 2 greenhouse to cannabis, adding 40 metric tons annual capacity by 2027, funded by $40M from produce sale.

**【CFO Financial Commentary】**
- **Revenue & Profitability**: Consolidated sales $59.9M (+12% YoY), with Canadian cannabis segment EBITDA $16.5M (+150% YoY). Netherlands EBITDA $1.2M, U.S. cannabis margin improved to 63%.
- **Cash & Debt**: $65M cash (net $29M), $39M debt post-refinancing. Free cash flow $12M YoY, supporting growth investments.
- **Produce Impact**: $19.1M gain from produce sale, with retained assets generating $6.4M EBITDA (incl. $4.3M non-recurring settlement).

**【Q&A Highlights】**
- **Expansion Rationale**: Low $7M investment to convert existing assets, prudent supply-demand matching, and $50M+ unfulfilled international demand.
- **Market Dynamics**: Canada's competitive shakeout, with focus on profitable SKUs; international markets (Germany, U.K.) driving growth despite regulatory noise.
- **U.S. Strategy**: Patient approach to federal rescheduling, leveraging Texas greenhouse for potential entry, while avoiding M&A for now.
- **2026 Outlook**: Netherlands Phase 2 and Canada expansion to drive continued margin expansion, targeting upper end of 30-40% gross margin range.

Village Farms International, Inc. (VFF) Q2 2025 Earnings Call Transcript

- **$40M cash infusion**: Privatized 67% of produce division into Vanguard Foods, retaining 37.9% equity and 5M sq ft of cannabis expansion capacity.
- **36% cannabis gross margin**: Q1 Canadian cannabis EBITDA up 75% to CAD9.6M, driven by 285% growth in international medical exports.
- **Netherlands expansion**: Phase 2 greenhouse to quadruple production to 12,000 kg/year, targeting 15.8% EBITDA margin in first year.
- **Stable cash flow**: $15M cash on hand, improving to net cash post-transaction. D1 facility generates $10M+ annual EBITDA.
- **Hemp opportunity**: GMP-certified manufacturing capabilities open to co-manufacturing partnerships as states tighten regulations.

**【CEO Summary Section】**
- Announced transformative transaction with Sweat Equities to create Vanguard Foods, privatizing 67% of fresh produce division and retaining 37.9% ownership. Received $40M cash proceeds and retained 5M sq ft of greenhouse assets for cannabis expansion.
- Transaction unlocks value for both produce and cannabis businesses, with Vanguard backed by $80M in capital for roll-up strategy in North America.
- Canadian cannabis Q1 revenue grew 285% YoY in international medical exports, driven by Germany and New Zealand markets. Gross margin expanded to 36% (vs 25% Q1 2024), with adjusted EBITDA up 75% to CAD9.6M.
- Netherlands operations contributed $485K in first month of sales, with Phase 2 expansion expected to quadruple production capacity by Q1 2026.

**【CFO Financial Highlights】**
- Consolidated Q1 2025 revenue $77M (flat vs Q1 2024), with net loss $6.7M due to $4.3M non-cash charge from Texas dust storm crop damage.
- Canadian cannabis segment: 
  - Net sales CAD50M (flat YoY), with 285% growth in international medical exports.
  - Gross margin 36%, up from 25% YoY. Adjusted EBITDA CAD9.6M (75% YoY growth).
  - Non-branded sales CAD9M (3% YoY growth) at higher margins, offsetting 22% decline in branded retail sales.
- US cannabis: Q1 sales $3.9M (trending lower due to hemp regulations), but gross margin 66% and positive EBITDA.
- Clean Energy: $300K net income from RNG royalties.
- Cash position $15M, with $50M working capital. Post-transaction net debt expected to be $19.3M, improving to net cash post-5M revolver payoff.

**【Q&A Key Points】**
- Capital allocation: Focus on organic growth in Netherlands (Phase 2 expansion to 12,000 kg annual capacity) and potential D2 greenhouse conversion in Canada. No M&A plans.
- Non-branded channel: Average selling prices up YoY, driven by reduced supply and international demand. Expect continued margin expansion.
- Netherlands market: 590 coffee shops mandated to buy legal product, with only 7 licensed producers. Leli Holland positioned to capture share.
- Hemp manufacturing: Open to co-manufacturing partnerships for GMP-certified products as states adopt stricter regulations.
- Vanguard transaction: Fairness opinion validates $80M valuation. Retained D1 facility generates stable $10M+ annual EBITDA.


Village Farms International (VFF)-13 May 25-2025 Q1 Earnings call transcript

- **Revenue Resilience**: Q4 2024 revenue up 11% YoY to $83M, driven by Canadian cannabis (+31% organically) and fresh produce expansion.
- **Market Leadership**: #3 in Canada with 10.8% dried flower share; Super Toast vapes rank #6 nationally.
- **International Surge**: Q4 medical exports up 113% YoY; 2025 target to triple 2024 exports. Netherlands rec market expansion begins with Phase 2 facility.
- **Profitability Focus**: 33% Canadian cannabis gross margin (vs 23% prior year); $7M Q4 EBITDA (excluding write-down).
- **Tariff Preparedness**: 60% U.S. produce imports may shift to Texas if tariffs apply; 2025 Canadian produce sales expected to rise.

**【CEO Summary Section】**
- **Revenue Growth**: Q4 2024 revenue of $83 million (+11% YoY), full year $336 million (+18% YoY). Canadian cannabis net sales up 31% organically.
- **Market Leadership**: #3 in Canada with 23% branded retail growth; #1 in dried flower, #2 in pre-rolls. Super Toast vapes ranked #6 nationally.
- **International Expansion**: Q4 international medical exports up 113% YoY (Germany, Australia, UK). New Zealand market added post-Q4.
- **Fresh Produce & Energy**: $3.5M other income from vendor settlements; clean energy on track for $2M 2025 net income.
- **Tariff Strategy**: 60% of U.S. produce imports may shift to Texas if tariffs apply; 2025 Canadian produce sales expected to rise.

**【CFO Financial Commentary】**
- **Q4 Financials**: Net loss $8.6M ($0.08/share) vs $22.5M prior year. Adjusted EBITDA $7M (excluding $10.5M inventory write-down).
- **Segment Performance**: 
  - **Fresh Produce**: Q4 sales $43.3M (+17% YoY), EBITDA $4.1M (vs -$0.6M prior year).
  - **Canadian Cannabis**: Q4 sales CAD 62.1M (+10% YoY). Gross margin 33% (vs 23% prior year). Adjusted EBITDA CAD -9.1M (including write-down).
  - **U.S. Cannabis**: Q4 EBITDA positive $0.3M vs -$0.6M prior year.
- **Cash Flow**: Full year operating cash flow $10.5M; Q4 cash $24.6M, working capital $53.8M.
- **Debt Management**: Refinancing Pure Sunfarms debt to Feb 2028; Dutch lender discussions for Leli Holland debt.

**【Q&A Key Highlights】**
- **Inventory Write-Down Impact**: No top-line impact; decision to focus on quality led to $10.5M non-cash charge.
- **Canada Strategy**: Prioritize profitable growth; Q4 dried flower share +120bps to 10.8%. Exit low-margin categories.
- **Netherlands Expansion**: Phase 2 facility to quadruple production; Q4 2025 harvests underway, pricing aligns with forecasts.
- **International Growth**: 2025 medical exports target: triple 2024 CAD 8.4M. Netherlands rec market separate from medical exports.
- **Competitive Position**: High-quality flower demand resilient; 7/10 Dutch LPs operational, quality differentiation drives share.

Village Farms International (VFF)-13 Mar 25-2024 Q4 Earnings call transcript

Village Farms International (VFF)-7 Nov 24-2024 Q3 Earnings call transcript

Village Farms International (VFF)-8 Aug 24-2024 Q2 Earnings call transcript

Village Farms International (VFF)-8 May 24-2024 Q1 Earnings call transcript

Village Farms International (VFF)-13 Mar 24-2023 Q4 Earnings call transcript

Village Farms International (VFF)-8 Nov 23-2023 Q3 Earnings call transcript

Village Farms International (VFF)-9 Aug 23-2023 Q2 Earnings call transcript

Village Farms International (VFF)-9 Mar 23-2022 Q4 Earnings call transcript

Village Farms International (VFF)-9 Nov 22-2022 Q3 Earnings call transcript

Village Farms International (VFF)-9 Aug 22-2022 Q2 Earnings call transcript

Village Farms International (VFF)-10 May 22-2022 Q1 Earnings call transcript

Village Farms International (VFF)-1 Mar 22-2021 Q4 Earnings call transcript

Village Farms International (VFF)-10 Nov 21-2021 Q3 Earnings call transcript

Village Farms International (VFF)-9 Aug 21-2021 Q2 Earnings call transcript

Village Farms International (VFF)-10 May 21-2021 Q1 Earnings call transcript

Village Farms International (VFF)-16 Mar 21-2020 Q4 Earnings call transcript

Village Farms International (VFF)-13 Nov 20-2020 Q3 Earnings call transcript

Village Farms International (VFF)-13 Aug 20-2020 Q2 Earnings call transcript

Village Farms International (VFF)-15 May 20-2020 Q1 Earnings call transcript

Village Farms International (VFF)-31 Mar 20-2019 Q4 Earnings call transcript

Village Farms International (VFF)-15 Nov 19-2019 Q3 Earnings call transcript

- **Record Q2 Performance**: 125% sales growth, 84% gross margin, and 78% EBITDA margin highlight Pure Sunfarms' operational excellence.
- **Cost Leadership**: $0.65/gram production cost, down 50% year-over-year, with potential for further declines.
- **Capacity Expansion**: 150,000 kg annual capacity by end-2020 and 300,000 kg+ with Delta 1 conversion.
- **US Hemp/CBD Growth**: 720 acres of outdoor cultivation in 2019, with extraction facilities and Texas greenhouse projects driving near-term revenue.

**【CEO Summary Section】**
- **Q2 Financial Highlights**: Pure Sunfarms achieved a 125% sequential sales increase to $32.4 million CAD, with a gross margin of 84% and EBITDA margin of 78%. Cost of goods sold dropped to $0.65 per gram, down from $1.35 in Q1.
- **Capacity Expansion**: Delta 3 facility reached full production (75,000 kg annually), and Delta 2 conversion is underway, targeting Q2 2020 for revenue contribution. Total capacity could double to 150,000 kg by end-2020.
- **US Hemp/CBD Strategy**: 720 acres of outdoor hemp cultivation in 2019, with extraction facilities in Georgia and Colorado. Texas greenhouse conversion for CBD production is pending regulatory approval.

**【CFO Financial Commentary】**
- **Cost Dynamics**: Q2 production costs benefited from summer seasonality, with expected increases in Q4. Full-year cost of goods sold is expected to average $0.82 per gram.
- **Bio Asset Growth**: Q2 bio asset balance of $36.4 million CAD (vs. $18.2 million CAD in Q1) signals strong Q3 revenue potential.
- **Liquidity**: The business generates consistent positive cash flow, supporting expansion into hemp and CBD.

**【Q&A Key Takeaways】**
- **Packaging License Progress**: Pure Sunfarms awaits Health Canada approval to sell directly to retailers, which could unlock higher pricing. Discussions with other provinces are ongoing.
- **CBD Product Strategy**: Focus on high-margin oils and smokable flower, with extraction facilities set to launch in early 2020.
- **Long-Term Margin Outlook**: Management expects to maintain high gross margins through vertical integration and cost leadership, with potential for 30%+ of revenue from cannabis 2.0 products by 2020.

Actual				0.08	0	0.02	0.12	-0.1	-0.06	0.01	0.03	-0.07	-0.41	-0.1	-0.54	-0.06	-0.01	-0.01	-0.2	-0.03	-0.21	-0.01	-0.08	-0.06	0.1	0.08	0.01
Forecast				-0.05	-0.0225	-0.01	0.005	-0.0267	-0.0217	-0.0217	0.01	-0.0033	-0.0733	-0.086	-0.0629	-0.048	-0.042	-0.0396	-0.0186	-0.0249	-0.02	-0.0265	-0.0189	-0.0119	-0.0145	0.0253	0.0432
Surprise	0.00%	0.00%	0.00%	+260.00%	+100.00%	+300.00%	+2300.00%	-274.53%	-176.50%	+146.08%	+200.00%	-2021.21%	-459.35%	-16.28%	-758.51%	-25.00%	+76.19%	+74.75%	-975.27%	-20.48%	-950.00%	+62.26%	-323.28%	-404.20%	+789.66%	+216.21%	-76.85%

VFF

VFF fundamentals

VFF Q4 2025 Earnings

Earnings Call

You can ask Aime

VFF

VFF fundamentals

VFF Q4 2025 Earnings

Earnings Call

VFF Earnings Call Summary for Q4/20258:30 AM on Mar 12, 2026

VFF Earnings Call Summary for Q3/20258:30 AM on Nov 10, 2025

VFF Earnings Call Summary for Q2/20258:30 AM on Aug 11, 2025

VFF Earnings Call Summary for Q1/20258:30 AM on May 13, 2025

VFF Earnings Call Summary for Q4/20248:30 AM on Mar 13, 2025

You can ask Aime